0001193125-24-070839 Sample Contracts

Portions of this exhibit have been redacted in compliance with Regulation S-K Item 601(a)(6). ENLIVEN THERAPEUTICS, INC. SECURITIES PURCHASE AGREEMENT

Securities Purchase Agreement • March 19th, 2024 • Enliven Therapeutics, Inc. • Pharmaceutical preparations • New York

• Contract Type
  Securities Purchase Agreement
• Filed
  March 19th, 2024
• Company
  Enliven Therapeutics, Inc.
• Industry
  Pharmaceutical preparations
• Jurisdiction
  New York

This Securities Purchase Agreement (the “Agreement”) is made as of March 19, 2024 (the “Effective Date”), by and among Enliven Therapeutics, Inc., a Delaware corporation (the “Company”), and each of the purchasers whose names and addresses are set forth on the signature pages hereof (each, a “Purchaser” and, collectively, the “Purchasers”).